First-generation 5-HT3 receptor antagonists (continuous infusion)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for First-generation 5-HT3 receptor antagonists (continuous infusion), covering 2023-07-21 to 2026-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Continuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With Dexamethasone [Phase 3]